Soligenix
SNGX
#10411
Rank
C$16.03 M
Marketcap
C$1.59
Share price
-0.87%
Change (1 day)
-39.33%
Change (1 year)

Earnings for Soligenix (SNGX)

Earnings in 2025 (TTM): -C$17.45 Million

According to Soligenix's latest financial reports the company's current earnings are N/A. In 2024 the company made an earning of -C$13.04 Million a decrease over its 2023 earnings that were of -C$10.61 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Soligenix from 1998 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) -C$17.45 Million33.83%
2024 -C$13.04 Million22.96%
2023 -C$10.61 Million-45.74%
2022 -C$19.54 Million11.88%
2021 -C$17.47 Million-32.37%
2020 -C$25.83 Million83.18%
2019 -C$14.1 Million11.57%
2018 -C$12.64 Million19.29%
2017 -C$10.6 Million33%
2016 -C$7.97 Million-19.7%
2015 -C$9.92 Million5.16%
2014 -C$9.43 Million
2010 -C$10.65 Million26.12%
2009 -C$8.44 Million75.1%
2008 -C$4.82 Million-45.38%
2007 -C$8.83 Million-22.84%
2006 -C$11.44 Million66.15%
2005 -C$6.89 Million-16.65%
2004 -C$8.26 Million13.28%
2003 -C$7.29 Million-11.88%
2002 -C$8.28 Million-59.44%
2001 -C$20.4 Million378.18%
2000 -C$4.27 Million-38.53%
1999 -C$6.94 Million-18.43%
1998 -C$8.51 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Johnson & Johnson
JNJ
C$46.79 B-271,360.99%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
C$14.21 B-82,500.21%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
C$10.73 B-62,347.25%๐Ÿ‡ซ๐Ÿ‡ท France
Onconova Therapeutics
ONTX
-C$25.33 Million 46.79%๐Ÿ‡บ๐Ÿ‡ธ USA
Athersys
ATHX
-C$58.25 Million 237.64%๐Ÿ‡บ๐Ÿ‡ธ USA
Teva Pharmaceutical Industries
TEVA
C$3.00 B-17,498.48%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel
Cleveland BioLabs
CBLI
-C$3.84 Million-77.75%๐Ÿ‡บ๐Ÿ‡ธ USA
Emergent BioSolutions
EBS
C$0.23 B-1,436.42%๐Ÿ‡บ๐Ÿ‡ธ USA